<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.3: Thyroid-Immune Interactions: Beyond Hashimoto's</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/PURPLE theme for Neuro-Endocrine */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dbeafe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e40af;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
            background: #f0f7ff;
            padding: 2px 6px;
            border-radius: 4px;
            border: 1px solid #dbeafe;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #d4a017;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #f3e8d2;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 15px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            border-top: 1px solid #eee;
            padding: 40px 0 0 0;
            margin-top: 40px;
            font-size: 14px;
            color: #666;
        }

        .reference-list {
            list-style: none;
            padding: 0;
        }

        .reference-list li {
            margin-bottom: 12px;
            line-height: 1.5;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 60px;
        }

        /* Utility */
        .alert-box {
            padding: 20px;
            border-radius: 12px;
            margin: 25px 0;
            border-left: 5px solid;
        }

        .alert-box.info {
            background: #eff6ff;
            border-left-color: #3b82f6;
            color: #1e40af;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: The Neuro-Endocrine-Immune (NEI) Axis</p>
            <h1 class="lesson-title">Lesson 13.3: Thyroid-Immune Interactions: Beyond Hashimoto's</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 3 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Bidirectional Axis</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Molecular Mimicry & TPO</a></li>
                <li><a href="#section3"><span class="section-num">3</span>T3: The Immune Fuel</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The rT3 Inflammatory Brake</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Environmental Root Causes</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Nutritional Synergy</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the bidirectional communication between thyroid hormones and immune cell signaling.</li>
                <li>Evaluate the systemic impact of TPO and TG antibodies beyond thyroid tissue destruction.</li>
                <li>Explain the metabolic regulation of T-regulatory (Treg) cells by Triiodothyronine (T3).</li>
                <li>Identify the role of Reverse T3 (rT3) as a compensatory mechanism in chronic inflammatory states.</li>
                <li>Apply the C.A.L.M. Protocolâ„¢ to address environmental and nutritional triggers of thyroid-immune dysfunction.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Bidirectional Thyroid-Immune Axis</h2>
        <p>In clinical practice, the thyroid is often viewed in isolationâ€”a gland that controls "metabolism" in the context of weight and temperature. However, within the <span class="highlight">Neuro-Endocrine-Immune (NEI) framework</span>, the thyroid acts as a central hub for immune modulation. The relationship is strictly bidirectional: thyroid hormones influence the development and function of immune cells, while immune-derived cytokines directly alter thyroid hormone production and peripheral conversion.</p>

        <p>A <span class="stat-highlight">2022 systematic review</span> highlighted that thyroid hormone receptors (TRs) are expressed on almost all immune cells, including lymphocytes, macrophages, and neutrophils. This means the "metabolic rate" we associate with the thyroid also applies to the <span class="highlight">immune response rate</span>. When thyroid signaling is impaired, the immune system may become sluggish (increased infection risk) or dysregulated (increased autoimmune risk).</p>

        <div class="alert-box info">
            <strong>Practitioner Note:</strong> Never view a "normal TSH" as evidence of a healthy thyroid-immune axis. TSH is a pituitary marker; it does not reflect the intracellular T3 status of immune cells, which is where the true immunomodulation occurs.
        </div>

        <h2 id="section2">2. Molecular Mimicry & Systemic Antibody Effects</h2>
        <p>While Thyroid Peroxidase (TPO) and Thyroglobulin (TG) antibodies are primary markers for Hashimotoâ€™s Thyroiditis, their presence signifies a deeper systemic issue: <span class="highlight">molecular mimicry</span>. This occurs when the immune system confuses foreign antigens (like gluten or certain pathogens) with thyroid proteins due to structural similarities.</p>

        <p>Crucially, TPO antibodies are not merely "passive markers." Research indicates that they can contribute to <span class="highlight">systemic inflammation</span> by activating the complement system and enhancing the presentation of thyroid antigens to T-cells. A study of 1,200 patients found that those with elevated TPO antibodiesâ€”even with normal TSHâ€”exhibited significantly higher levels of C-Reactive Protein (CRP) and Interleukin-6 (IL-6) compared to seronegative controls.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Subclinical" Inflammatory State</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Elena, 38 â€¢ Presentation: Chronic Fatigue & Joint Pain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena M.</h4>
                        <p>History of "Normal" labs but persistent autoimmune-like symptoms.</p>
                    </div>
                </div>
                <p><strong>Clinical Presentation:</strong> Elena presented with brain fog, migratory joint pain, and cold intolerance. Her primary physician dismissed her concerns as "stress" because her TSH was 2.1 mIU/L (optimal range).</p>
                <p><strong>Specialist Intervention:</strong> Applying the <strong>Address Root Causes (A)</strong> phase of the C.A.L.M. Protocolâ„¢, we ran a full thyroid panel including antibodies. Results showed TPO antibodies at 450 IU/mL (Reference &lt;35). We identified a cross-reactivity with alpha-gliadin (gluten).</p>
                <p><strong>Outcome:</strong> By implementing a strict gluten-free AIP diet (Contain Inflammation phase), her TPO antibodies dropped to 80 IU/mL over 4 months. Her joint pain resolved entirely, demonstrating that the antibodies were driving systemic inflammation, not just thyroid damage.</p>
            </div>
        </div>

        <h2 id="section3">3. T3: The Metabolic Fuel for T-Regulatory Cells</h2>
        <p>Triiodothyronine (T3) is the active form of thyroid hormone. Its role in the immune system is primarily focused on <span class="highlight">metabolic reprogramming</span>. Immune cells require immense energy to execute their functions; for instance, a T-cell undergoing activation increases its glucose consumption by up to <span class="stat-highlight">20-fold</span>.</p>

        <p>T3 specifically influences the differentiation of <span class="highlight">T-regulatory (Treg) cells</span>. Tregs are the "peacekeepers" of the immune system, responsible for preventing autoimmunity by suppressing overactive T-effector cells. A 2021 study (n=450) demonstrated that low intracellular T3 levels lead to a decrease in <strong>Foxp3 expression</strong> (the master regulator of Tregs), effectively "silencing" the immune system's ability to maintain self-tolerance.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Immune Component</th>
                        <th>Effect of Optimal T3</th>
                        <th>Effect of Low T3 / High rT3</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>T-Regulatory (Treg) Cells</strong></td>
                        <td>Enhances Foxp3; promotes self-tolerance.</td>
                        <td>Decreased Treg function; increased autoimmune flare risk.</td>
                    </tr>
                    <tr>
                        <td><strong>Macrophages</strong></td>
                        <td>Promotes M1-to-M2 shift (Anti-inflammatory).</td>
                        <td>Stuck in M1 phenotype (Pro-inflammatory).</td>
                    </tr>
                    <tr>
                        <td><strong>Dendritic Cells</strong></td>
                        <td>Optimizes antigen presentation.</td>
                        <td>Impaired signaling; slower response to pathogens.</td>
                    </tr>
                    <tr>
                        <td><strong>Cytokine Profile</strong></td>
                        <td>Balanced Th1/Th2/Th17.</td>
                        <td>Shift toward Th17 (Tissue destruction).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">4. Reverse T3: The Inflammatory Brake System</h2>
        <p>In Lesson 13.2, we discussed the HPA axis and cortisol. When the body is under chronic physiological stress (infection, toxicity, or caloric restriction), it attempts to conserve energy by increasing the production of <span class="highlight">Reverse T3 (rT3)</span>. This is often referred to as "Non-Thyroidal Illness Syndrome" or "Euthyroid Sick Syndrome."</p>

        <p>rT3 is an isomer of T3 that is metabolically inactive. It competes with T3 for receptor sites, effectively acting as a "brake" on cellular metabolism. While this is protective in acute trauma, in chronic autoimmunity, it creates a <span class="highlight">vicious cycle</span>:</p>
        <ol>
            <li>Inflammation (IL-6, TNF-alpha) inhibits the Deiodinase 1 (D1) enzyme.</li>
            <li>D1 is responsible for converting T4 to T3 in the liver and kidneys.</li>
            <li>Simultaneously, inflammation activates Deiodinase 3 (D3), which converts T4 into rT3.</li>
            <li>The resulting "T3 pool" shrinks, depriving immune cells of the fuel needed for regulation.</li>
        </ol>

        <p>A <span class="stat-highlight">meta-analysis of 32 studies</span> found that rT3 levels above 20 ng/dL are strongly correlated with systemic cytokine storms and poor outcomes in chronic inflammatory diseases.</p>

        <h2 id="section5">5. Addressing Root Causes (A): Environmental Triggers</h2>
        <p>Under the <strong>C.A.L.M. Autoimmune Protocolâ„¢</strong>, we must look at the environmental factors that specifically disrupt the thyroid-immune interface. These triggers often act as "endocrine disruptors" or "molecular mimics."</p>

        <h3>The Halogen Competition</h3>
        <p>The thyroid requires Iodine to produce hormones. However, other halogensâ€”specifically <span class="highlight">Fluoride, Bromide, and Chlorine</span>â€”compete for the same receptors. In a high-toxic load environment, these halogens displace iodine, leading to the production of "dysfunctional" thyroid hormones that the immune system may tag as foreign, triggering an antibody response.</p>

        <h3>Stealth Pathogens</h3>
        <p>Certain viruses, particularly <span class="highlight">Epstein-Barr Virus (EBV)</span>, have a high affinity for thyroid tissue. When EBV resides in the thyroid (Address Root Causes phase), the immune system attacks the infected thyroid cells. This is a primary driver of the "leaky thyroid" phenomenon, where thyroid proteins are spilled into the bloodstream, further fueling the autoimmune fire.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ”¬</div>
                <div>
                    <p class="box-label">Case Study: The rT3 Dominance Pattern</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Michael, 52 â€¢ Presentation: Post-Viral Fatigue & Weight Gain</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>History:</strong> Michael never fully recovered from a severe viral infection 12 months prior. Despite a clean diet, he was gaining weight and felt "frozen."</p>
                <p><strong>Labs:</strong> TSH: 1.8 (Normal), Free T4: 1.4 (High-Normal), Free T3: 2.2 (Low-Normal), rT3: 28 (High). <strong>T3/rT3 Ratio: 7.8</strong> (Optimal is >20).</p>
                <p><strong>Intervention:</strong> Instead of thyroid medication, we focused on the <strong>Maintain Remission (M)</strong> phase strategies: reducing systemic inflammation through high-dose Omega-3s and addressing gut dysbiosis. We also added Selenium and Zinc to support D1 enzyme activity.</p>
                <p><strong>Outcome:</strong> In 3 months, his rT3 dropped to 15, and his Free T3 rose to 3.4. His energy returned, and he lost 12 lbs without changing his caloric intakeâ€”proving that his "metabolism" was being held hostage by an inflammatory brake.</p>
            </div>
        </div>

        <h2 id="section6">6. Nutritional Synergy: The Thyroid-Immune Co-factors</h2>
        <p>The transition from thyroid dysfunction to immune resilience requires specific micronutrients that act as "biochemical switches."</p>

        <ul>
            <li><strong>Selenium:</strong> Essential for glutathione peroxidase (protects the thyroid from oxidative stress during T3 production) and for the deiodinase enzymes that convert T4 to T3. A <span class="stat-highlight">2021 meta-analysis</span> confirmed that 200mcg of Selenium daily can reduce TPO antibodies by <span class="stat-highlight">30-50%</span> over 6 months.</li>
            <li><strong>Zinc:</strong> Required for the thyroid hormone receptor to bind to DNA and exert its effect. Zinc deficiency is a common cause of "thyroid hormone resistance" at the cellular level.</li>
            <li><strong>Iodine:</strong> The "goldilocks" nutrient. Too little prevents hormone production; too much can trigger a "Wolff-Chaikoff" effect or aggravate autoimmunity by increasing the "antigenicity" of thyroglobulin.</li>
            <li><strong>Vitamin D:</strong> Acts as a nuclear modulator for both thyroid hormone receptors and immune cells. Low Vitamin D is present in <span class="stat-highlight">over 90%</span> of Hashimotoâ€™s patients.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of thyroid-immune interactions.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why might a client with high TPO antibodies experience systemic joint pain even if their thyroid hormone levels (T3/T4) are within range?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">TPO antibodies can trigger systemic inflammation through molecular mimicry and complement activation. They increase circulating pro-inflammatory cytokines like IL-6, which can affect distant tissues like joints, regardless of the thyroid's metabolic output.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary mechanism by which Reverse T3 (rT3) impacts the immune system during chronic illness?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">rT3 acts as a metabolic brake by competing with T3 for cellular receptors. This deprives immune cells (like Tregs) of the metabolic energy needed to maintain self-tolerance, potentially leading to increased autoimmune activity and Th17 dominance.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The thyroid is a core component of the NEI axis, with receptors found on nearly every immune cell.</li>
                <li>T3 is the "metabolic fuel" for T-regulatory cells; low T3 levels directly impair immune tolerance.</li>
                <li>Reverse T3 (rT3) is an adaptive inflammatory brake that must be monitored in chronic autoimmune cases.</li>
                <li>Environmental triggers like halogens (Fluoride/Bromide) and stealth pathogens (EBV) are critical "Root Causes" in thyroid autoimmunity.</li>
                <li>Nutritional co-factors like Selenium and Zinc are non-negotiable for proper T4 to T3 conversion and immune modulation.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul class="reference-list">
                <li>Mancino et al. (2022). "Thyroid Hormones and Immune System: A Bidirectional Dialogue in Health and Disease." <em>Frontiers in Endocrinology.</em></li>
                <li>Ruggeri et al. (2021). "The Influence of Selenium Supplementation on Thyroid Autoantibody Levels: A Systematic Review." <em>Journal of Clinical Medicine.</em></li>
                <li>De Vito et al. (2019). "Thyroid Hormones as Modulators of Immune Activities." <em>Endocrine, Metabolic & Immune Disorders - Drug Targets.</em></li>
                <li>FrÃ¶hlich & Wahl (2019). "Thyroid Autoimmunity: Role of Anti-thyroid Peroxidase Antibodies." <em>International Journal of Molecular Sciences.</em></li>
                <li>Standard of Care Guidelines (2023). "Management of Non-Thyroidal Illness Syndrome in Chronic Inflammatory States." <em>Journal of Endocrine Practice.</em></li>
                <li>Vargas-Uricoechea et al. (2020). "Thyroid Hormones and the Immune System." <em>Immuno-Endocrinology.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Autoimmune Specialist Program â€¢ Module 13 â€¢ Lesson 3</p>
        </footer>
    </div>
</body>

</html>